IMPLICATION OF INSULIN GENE-THERAPY SYSTEM IN DIABETES TREATMENT : CONSTRUCTION OF BIO-ARITFICIAL PANCREATIC B CELL

胰岛素基因治疗系统在糖尿病治疗中的意义:生物人工胰腺B细胞的构建

基本信息

  • 批准号:
    06557061
  • 负责人:
  • 金额:
    $ 9.73万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
  • 财政年份:
    1994
  • 资助国家:
    日本
  • 起止时间:
    1994 至 1995
  • 项目状态:
    已结题

项目摘要

In this study, we transfected human insulin gene in some eukaryotic cells ; CHO cells, 3T12-3 fibroblasts, pituitary ACTH secreting tumor cells (AtT20) or murine insulinoma cells (MIN6 cells). And their characteristics were evaluated in vitro and in vivo.Expression of human insulin gene in these cells was confirmed by Northern blot analysis. Radioimmunoassay and HPLC revealed that human insulin gene transfected CHO cells and 3T12-3 fibroblasts secreted proinsulin into culture medium, whereas human insulin gene transfected AtT20 cells and MIN6 cells did insulin. In addition, all of these human insulin gene transfected cells induced hypoglycemia, when these cells were transplanted into nude mouse. Nude mouse died at 15 days after the transplantation of insulin gene transfected CHO cells and at 24 hours after the transplantation of insulin gene transfected MIN6 cells.Human insulin gene transfected MIN6 cells showed glucose concentration-dependent insulin secretion in culture media, but human insulin gene transfected AtT20 cells did not. Also, in the perifusion experiment, human insulin gene transfected MIN6 cells revealed biphasic insulin secretion in responce to glucose, but human insulin gene transfected AtT20 cells did not. On the other hand, AtT20 cell transfected with insulin gene, glucose transporter type 2 gene and glucokinase gene showed the glucose concentration-dependent insulin secretion in culture media, although it did not reveal biphasic insulin secretion in responce to glucose in the perifusion experiment.The construction of pancreatic B cell functions gene-biotechnologically in eukaryotic cells might imply not only the understanding of unknown mechanisms of glucose sensing system, signal transduction system and insulin secretion in pancreatic B cell, but also the possible-model of insulin gene-therapy in diabetes treatment.
本研究将人胰岛素基因转染到CHO细胞、3 T12 -3成纤维细胞、垂体ACTH分泌瘤细胞(AtT 20)和小鼠胰岛素瘤细胞(MIN 6)中。北方印迹分析证实了人胰岛素基因在细胞中的表达。放射免疫分析和高效液相色谱分析显示,转染人胰岛素基因的CHO细胞和3 T12 -3成纤维细胞分泌胰岛素原,而转染人胰岛素基因的AtT 20细胞和MIN 6细胞分泌胰岛素。此外,这些人胰岛素基因转染细胞移植到裸鼠体内后,均能诱导低血糖。转染人胰岛素基因的CHO细胞移植后15 d和转染人胰岛素基因的MIN 6细胞移植后24 h裸鼠死亡,转染人胰岛素基因的MIN 6细胞在培养液中显示出葡萄糖浓度依赖性的胰岛素分泌,而转染人胰岛素基因的AtT 20细胞则无此现象。在灌流实验中,人胰岛素基因转染的MIN 6细胞显示出对葡萄糖有反应的双相胰岛素分泌,而人胰岛素基因转染的AtT 20细胞则没有。另一方面,转染胰岛素基因、葡萄糖转运蛋白2基因和葡萄糖激酶基因的AtT 20细胞在培养基中显示葡萄糖浓度依赖性的胰岛素分泌,虽然在灌流实验中没有发现葡萄糖引起的胰岛素双相分泌,但胰腺B细胞功能基因的构建,在真核细胞中应用生物技术不仅意味着对胰腺B细胞葡萄糖敏感系统、信号转导系统和胰岛素分泌机制的了解,也是胰岛素基因治疗糖尿病的可能模式。

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SHICHIRI,M.et al.: "Pancreas transplantation, construction of pancreatic B cell by gene manupulati" GeKa Shinryo. 37 (in Japanese). 153-159 (1995)
SHICHIRI,M.et al.:“胰腺移植,通过基因操作构建胰腺 B 细胞”GeKa Shinryo。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
MOTOYOSHI,S.et al.: Mechanism of human insulin gene expression in eukaryotic cells.Insulin Kenkyu 1993 (in Japanese), 135 : 6 (1994)
MOTOYOSHI,S.et al.:真核细胞中人胰岛素基因表达的机制。Insulin Kenkyu 1993(日文),135:6(1994)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
七里元亮他: "人工膵島の現状-人工膵島vs遺伝子工学的膵B細胞の再構築" 臨床と研究. 72. 103-108 (1995)
Motosuke Shichiri 等人:“人工胰岛的现状 - 人工胰岛与基因工程胰腺 B 细胞重建”临床与研究,72. 103-108 (1995)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
本吉貞俊 他: "分子糖尿病学" 医学図書出版, 136 (1994)
Sadatoshi Motoyoshi 等:“分子糖尿病” Igaku Tosho Publishing,136(1994)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
SHICHIRI,M.: Developement of artificial endocrine pancreas and optimal glycemic control.Tiryou no Kaitaku : Aso Symposium 1993 (in Japanese), 180 (1994)
七里,M.:人工内分泌胰腺的开发和最佳血糖控制。Tiryou no Kaitaku:Aso Symposium 1993(日语),180(1994)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHICHIRI Motoaki其他文献

SHICHIRI Motoaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHICHIRI Motoaki', 18)}}的其他基金

Intracellular signal-transduction in oxidized LDL-induced macrophage growth in arterial wall.
氧化低密度脂蛋白诱导动脉壁巨噬细胞生长的细胞内信号转导。
  • 批准号:
    09671065
  • 财政年份:
    1997
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Non-invasive blood glucose measurement using infrared absorption spectroscopy with a CO_2 laser - design for miniaturization
使用 CO_2 激光红外吸收光谱进行无创血糖测量 - 小型化设计
  • 批准号:
    03557119
  • 财政年份:
    1991
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Development of non-invasive blood glucose measurement system : Application of laser absorption spectroscopy with an ATR prism
开发无创血糖测量系统:ATR棱镜激光吸收光谱的应用
  • 批准号:
    62870048
  • 财政年份:
    1987
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research

相似海外基金

Manipulation and engineering of lipid metabolic pathways in CHO cells to enhance processability of cell culture supernantants
CHO 细胞中脂质代谢途径的操作和工程,以增强细胞培养上清液的可加工性
  • 批准号:
    2873335
  • 财政年份:
    2023
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Studentship
Glycoengineering of CHO cells to express recombinant alpha-1 antitrypsin
CHO细胞的糖工程表达重组α-1抗胰蛋白酶
  • 批准号:
    10484110
  • 财政年份:
    2022
  • 资助金额:
    $ 9.73万
  • 项目类别:
Evaluation of antibody-heterogeneity in CHO cells
CHO 细胞中抗体异质性的评估
  • 批准号:
    20K15105
  • 财政年份:
    2020
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidating the signalling pathways important for antibody production and secretion in CHO cells
阐明 CHO 细胞中抗体产生和分泌的重要信号通路
  • 批准号:
    2467836
  • 财政年份:
    2020
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Studentship
Combinatorial approaches to engineer CHO cells to enhance production of difficult-to-express therapeutic proteins
改造 CHO 细胞的组合方法以增强难以表达的治疗性蛋白质的产生
  • 批准号:
    BB/T508615/1
  • 财政年份:
    2019
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Training Grant
Development of rapid production of antibody drugs using a single-copy gene expression system in CHO cells
开发利用 CHO 细胞单拷贝基因表达系统快速生产抗体药物
  • 批准号:
    19K05178
  • 财政年份:
    2019
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Utilization of chromosomal instability in CHO cells in recombinant protein production
在重组蛋白生产中利用 CHO 细胞染色体不稳定性
  • 批准号:
    19K21105
  • 财政年份:
    2018
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of a novel inducible expression system for the manufacture of therapeutic proteins from CHO cells.
开发一种新型诱导表达系统,用于从 CHO 细胞生产治疗性蛋白质。
  • 批准号:
    104199
  • 财政年份:
    2018
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Collaborative R&D
Developing novel biosensors for monitoring antibody production in CHO cells.
开发新型生物传感器来监测 CHO 细胞中抗体的产生。
  • 批准号:
    1983469
  • 财政年份:
    2018
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Studentship
Cell and Process Engineering for Transient Expression of Recombinant Proteins in CHO Cells
CHO 细胞中重组蛋白瞬时表达的细胞和工艺工程
  • 批准号:
    2122943
  • 财政年份:
    2018
  • 资助金额:
    $ 9.73万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了